Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors. [Society of Interventional Radiology]

info@guidelines.gov (NGC), 2009

National Guideline Clearinghouse | Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors.
Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors.
Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors.
(271525004); (122463005); (129335008); (240917005); (408455009); (93870000); (363406005); (363351006); (126837005); (126851005); (426830009); (109841003); (187769009); (25370001); (94381002)
To present a position statement on the use of percutaneous radiofrequency ablation for the treatment of liver tumors
Patients with primary or secondary liver tumors who are poor candidates for or ineligible for surgical resection or who are awaiting orthotopic liver transplantation
RF ablation in conjunction with transarterial chemoembolization or bland embolization (considered but not recommended)
An in-depth literature search is performed using electronic medical literature databases.
Methods Used to Assess the Quality and Strength of the Evidence
A formal cost analysis was not performed and published cost analyses were not reviewed.
The choice of a percutaneous, laparoscopic, or open surgical approach remains controversial, although clear advantages of one over the other may apply in specific clinical circumstances.